Fullerton Health Corporation Limited (“Fullerton Health” or the “Company”) announced today that it has come into an agreement with Far East Drug (B.V.I.) Co. Ltd. (“Far East Drug” or “FED”), involving an investment in a majority stake in the business by Far East Drug.
Fullerton Health Group (FHG) continues to make important strides toward integrating its sustainability goals within its operations and ecosystem. The release of its FY2022 Sustainability Report underscores the Group’s commitments and progress in achieving its sustainability goals. The report reflects FHG’s strong partnerships and collective action in building a sustainable future.
In a post pandemic and inflationary era, corporations are marked by dual pressures of regional market expansion and cost containment, Global Assistance and Healthcare (GAH)
Fullerton Health Corporation Limited (“Fullerton Health” or the “Company”) announced today that it has completed a merger led by RRJ Capital (“RRJ”) involving an equity injection by the private equity firm and a senior loan totalling S$390 million. The merger delivers a stronger balance sheet and a new capital structure which will propel post-pandemic growth opportunities for the pan-Asian healthcare
Fullerton Healthcare CorporationLimited (“Fullerton Health” or the “Company”) is pleased to announce that it has reached a definitive settlement agreement
